vs
Side-by-side financial comparison of ImmunityBio, Inc. (IBRX) and SIFCO INDUSTRIES INC (SIF). Click either name above to swap in a different company.
ImmunityBio, Inc. is the larger business by last-quarter revenue ($38.3M vs $24.0M, roughly 1.6× SIFCO INDUSTRIES INC). SIFCO INDUSTRIES INC runs the higher net margin — 7.5% vs -161.8%, a 169.3% gap on every dollar of revenue. On growth, ImmunityBio, Inc. posted the faster year-over-year revenue change (407.0% vs 14.8%). SIFCO INDUSTRIES INC produced more free cash flow last quarter ($8.0M vs $-71.3M).
ImmunityBio, Inc. is a clinical-stage biotechnology company focused on developing next-generation immunotherapies and vaccine candidates targeting multiple cancer types and infectious diseases. It operates mainly in the U.S. market, with core R&D segments including cell therapy, antibody therapeutics, and targeted vaccine platforms designed to enhance patient treatment outcomes.
SIFCO Industries, Inc. (SIFCO), is a global metal component manufacturer based in Cleveland, Ohio.
IBRX vs SIF — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $38.3M | $24.0M |
| Net Profit | $-61.9M | $1.8M |
| Gross Margin | 99.0% | 21.6% |
| Operating Margin | -169.0% | 10.7% |
| Net Margin | -161.8% | 7.5% |
| Revenue YoY | 407.0% | 14.8% |
| Net Profit YoY | -4.7% | 177.3% |
| EPS (diluted) | $-0.06 | $0.29 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $38.3M | $24.0M | ||
| Q3 25 | $32.1M | $22.8M | ||
| Q2 25 | $26.4M | $22.1M | ||
| Q1 25 | $16.5M | $19.0M | ||
| Q4 24 | $7.6M | $20.9M | ||
| Q3 24 | $6.1M | $21.7M | ||
| Q2 24 | — | $22.0M | ||
| Q1 24 | — | $20.5M |
| Q4 25 | $-61.9M | $1.8M | ||
| Q3 25 | $-67.3M | $-429.0K | ||
| Q2 25 | $-92.6M | $3.4M | ||
| Q1 25 | $-129.6M | $-1.4M | ||
| Q4 24 | $-59.2M | $-2.3M | ||
| Q3 24 | $-85.7M | $-443.0K | ||
| Q2 24 | — | $72.0K | ||
| Q1 24 | — | $-1.6M |
| Q4 25 | 99.0% | 21.6% | ||
| Q3 25 | 99.4% | 9.6% | ||
| Q2 25 | 99.5% | 26.7% | ||
| Q1 25 | 99.6% | 8.3% | ||
| Q4 24 | — | 4.4% | ||
| Q3 24 | — | 10.7% | ||
| Q2 24 | — | 12.3% | ||
| Q1 24 | — | 7.3% |
| Q4 25 | -169.0% | 10.7% | ||
| Q3 25 | -173.5% | -1.7% | ||
| Q2 25 | -269.8% | 14.8% | ||
| Q1 25 | -390.1% | -4.1% | ||
| Q4 24 | -919.0% | -9.2% | ||
| Q3 24 | -1314.3% | -1.5% | ||
| Q2 24 | — | 0.7% | ||
| Q1 24 | — | -6.5% |
| Q4 25 | -161.8% | 7.5% | ||
| Q3 25 | -209.8% | -1.9% | ||
| Q2 25 | -350.3% | 15.4% | ||
| Q1 25 | -784.9% | -7.3% | ||
| Q4 24 | -783.4% | -11.1% | ||
| Q3 24 | -1404.0% | -2.0% | ||
| Q2 24 | — | 0.3% | ||
| Q1 24 | — | -7.8% |
| Q4 25 | $-0.06 | $0.29 | ||
| Q3 25 | $-0.07 | $-0.07 | ||
| Q2 25 | $-0.10 | $0.56 | ||
| Q1 25 | $-0.15 | $-0.23 | ||
| Q4 24 | $-0.08 | $-0.38 | ||
| Q3 24 | $-0.14 | $-0.07 | ||
| Q2 24 | — | $0.01 | ||
| Q1 24 | — | $-0.27 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $242.8M | $1.1M |
| Total DebtLower is stronger | — | $39.0K |
| Stockholders' EquityBook value | $-500.5M | $38.7M |
| Total Assets | $501.9M | $74.9M |
| Debt / EquityLower = less leverage | — | 0.00× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $242.8M | $1.1M | ||
| Q3 25 | $257.8M | $491.0K | ||
| Q2 25 | $153.7M | $2.0M | ||
| Q1 25 | $61.6M | $1.9M | ||
| Q4 24 | $149.8M | $3.1M | ||
| Q3 24 | $130.4M | $1.7M | ||
| Q2 24 | — | $3.4M | ||
| Q1 24 | — | $2.5M |
| Q4 25 | — | $39.0K | ||
| Q3 25 | — | $51.0K | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $0 | ||
| Q2 24 | — | $3.6M | ||
| Q1 24 | — | $4.1M |
| Q4 25 | $-500.5M | $38.7M | ||
| Q3 25 | $-524.3M | $36.9M | ||
| Q2 25 | $-570.7M | $35.8M | ||
| Q1 25 | $-591.4M | $32.4M | ||
| Q4 24 | $-489.1M | $33.7M | ||
| Q3 24 | $-745.1M | $30.4M | ||
| Q2 24 | — | $29.8M | ||
| Q1 24 | — | $29.7M |
| Q4 25 | $501.9M | $74.9M | ||
| Q3 25 | $519.0M | $73.4M | ||
| Q2 25 | $402.1M | $77.3M | ||
| Q1 25 | $303.8M | $78.8M | ||
| Q4 24 | $382.9M | $81.0M | ||
| Q3 24 | $364.6M | $104.6M | ||
| Q2 24 | — | $106.3M | ||
| Q1 24 | — | $104.2M |
| Q4 25 | — | 0.00× | ||
| Q3 25 | — | 0.00× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | 0.12× | ||
| Q1 24 | — | 0.14× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-70.4M | $8.1M |
| Free Cash FlowOCF − Capex | $-71.3M | $8.0M |
| FCF MarginFCF / Revenue | -186.2% | 33.3% |
| Capex IntensityCapex / Revenue | 2.4% | 0.4% |
| Cash ConversionOCF / Net Profit | — | 4.51× |
| TTM Free Cash FlowTrailing 4 quarters | $-308.8M | $11.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-70.4M | $8.1M | ||
| Q3 25 | $-68.9M | $726.0K | ||
| Q2 25 | $-79.7M | $371.0K | ||
| Q1 25 | $-85.9M | $2.8M | ||
| Q4 24 | $-85.1M | $-3.8M | ||
| Q3 24 | $-98.8M | $857.0K | ||
| Q2 24 | — | $382.0K | ||
| Q1 24 | — | $-3.2M |
| Q4 25 | $-71.3M | $8.0M | ||
| Q3 25 | $-69.6M | $566.0K | ||
| Q2 25 | $-80.8M | $310.0K | ||
| Q1 25 | $-87.0M | $2.7M | ||
| Q4 24 | $-87.3M | $-3.9M | ||
| Q3 24 | $-101.6M | $580.0K | ||
| Q2 24 | — | $-175.0K | ||
| Q1 24 | — | $-3.9M |
| Q4 25 | -186.2% | 33.3% | ||
| Q3 25 | -217.2% | 2.5% | ||
| Q2 25 | -305.9% | 1.4% | ||
| Q1 25 | -526.9% | 14.1% | ||
| Q4 24 | -1155.4% | -18.8% | ||
| Q3 24 | -1663.2% | 2.7% | ||
| Q2 24 | — | -0.8% | ||
| Q1 24 | — | -18.9% |
| Q4 25 | 2.4% | 0.4% | ||
| Q3 25 | 2.3% | 0.7% | ||
| Q2 25 | 4.1% | 0.3% | ||
| Q1 25 | 6.8% | 0.8% | ||
| Q4 24 | 28.0% | 0.5% | ||
| Q3 24 | 45.7% | 1.3% | ||
| Q2 24 | — | 2.5% | ||
| Q1 24 | — | 3.3% |
| Q4 25 | — | 4.51× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 5.31× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IBRX
Segment breakdown not available.
SIF
| Fixed Wing Aircraft Revenue | $10.5M | 44% |
| Commercial Revenue | $8.7M | 36% |
| Commercial Product And Other Revenue | $2.8M | 12% |
| Commercial Space | $1.1M | 5% |
| Other | $840.0K | 4% |
